Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure)
Publication
, Journal Article
O’Meara, E; Prescott, MF; Claggett, B; Rouleau, JL; Chiang, L-M; Solomon, SD; Packer, M; McMurray, JJV; Zile, MR
Published in: Circulation: Heart Failure
May 2018
Duke Scholars
Published In
Circulation: Heart Failure
DOI
EISSN
1941-3297
ISSN
1941-3289
Publication Date
May 2018
Volume
11
Issue
5
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Cardiovascular System & Hematology
- 3208 Medical physiology
- 3201 Cardiovascular medicine and haematology
- 1116 Medical Physiology
- 1102 Cardiorespiratory Medicine and Haematology
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Meara, E., Prescott, M. F., Claggett, B., Rouleau, J. L., Chiang, L.-M., Solomon, S. D., … Zile, M. R. (2018). Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circulation: Heart Failure, 11(5). https://doi.org/10.1161/circheartfailure.117.004446
O’Meara, Eileen, Margaret F. Prescott, Brian Claggett, Jean L. Rouleau, Lu-May Chiang, Scott D. Solomon, Milton Packer, John J. V. McMurray, and Michael R. Zile. “Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).” Circulation: Heart Failure 11, no. 5 (May 2018). https://doi.org/10.1161/circheartfailure.117.004446.
O’Meara E, Prescott MF, Claggett B, Rouleau JL, Chiang L-M, Solomon SD, et al. Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circulation: Heart Failure. 2018 May;11(5).
O’Meara, Eileen, et al. “Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).” Circulation: Heart Failure, vol. 11, no. 5, Ovid Technologies (Wolters Kluwer Health), May 2018. Crossref, doi:10.1161/circheartfailure.117.004446.
O’Meara E, Prescott MF, Claggett B, Rouleau JL, Chiang L-M, Solomon SD, Packer M, McMurray JJV, Zile MR. Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circulation: Heart Failure. Ovid Technologies (Wolters Kluwer Health); 2018 May;11(5).
Published In
Circulation: Heart Failure
DOI
EISSN
1941-3297
ISSN
1941-3289
Publication Date
May 2018
Volume
11
Issue
5
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Cardiovascular System & Hematology
- 3208 Medical physiology
- 3201 Cardiovascular medicine and haematology
- 1116 Medical Physiology
- 1102 Cardiorespiratory Medicine and Haematology
- 0601 Biochemistry and Cell Biology